Skip to main content
;

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

Standing Committee on Health (HESA)
42nd Parliament, 1st Session
Meeting No. 67
Thursday, September 14, 2017, 8:35 a.m. to 7:56 p.m.
Televised
Presiding
Bill Casey, Chair (Liberal)

Expand AllCollapse All
• Marilyn Gladu for Rachael Harder (Conservative)
• Ron McKinnon for Darshan Singh Kang (Liberal)
• Bill Blair (Liberal)
• Joël Lightbound (Liberal)
House of Commons
• Hugues La Rue, Procedural Clerk
 
Library of Parliament
• Karin Phillips, Analyst
• Robin MacKay, Analyst
Bill C-45, An Act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts
As individuals
• Michael DeVillaer, Assistant Professor, Policy Analyst, McMaster University
• Mark Kleiman, Professor of Public Policy, Marron Institute of Urban Management, New York University
• David Hammond, Professor, University of Waterloo, School of Public Health and Health Systems
• Steven Hoffman, Professor, Faculty of Health, Osgoode Hall Law School, York University
Canadian Nurses Association
• Lynda G. Balneaves, Registered Nurse and Medical and Non-Medical Cannabis Researcher
• Karey Shuhendler, Policy Advisor, Policy, Advocacy and Strategy
New Brunswick Medical Society
• Serge Melanson, Doctor
Nova Scotia Department of Health and Wellness
• Robert Strang, Chief Medical Officer of Health
Brazeau Seller LLP
• Trina Fraser, Partner
Department of Employment and Social Development
• Brenda Baxter, Director General, Workplace Directorate, Labour Program
• Eric Advokaat, Senior Director, Occupational Health and Safety, Workplace Directorate, Labour Program
Fasken Martineau DuMoulin LLP
• Norm Keith, Partner
Métis National Council
• Clara Morin Dal Col, Minister of Health
• Eduardo Vides, Senior Health Policy Advisor
• Wenda Watteyne, Senior Policy Advisor
Chiefs of Ontario
• Isadore Day, Ontario Regional Chief
Atlantic Convenience Stores Association
• Mike Hammoud, President
Non-Smokers' Rights Association
• Melodie Tilson, Director of Policy
• Pippa Beck, Senior Policy Analyst
RAND Drug Policy Research Center
• Beau Kilmer, Co-Director
Tousaw Law Corporation
• Kirk Tousaw, Lawyer
Transform Drug Policy Foundation
• Stephen Rolles, Senior Policy Analyst
Pursuant to the Order of Reference of Thursday, June 8, 2017, the Committee resumed consideration of Bill C-45, An Act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts.

Serge Melanson, by videoconferance from Moncton, New Brunswick, Mark Kleiman, by videoconference from New York, New York, Robert Strang, by videoconference from Halifax, Nova Scotia, Michael DeVillaer and Karey Shuhendler made statements and answered questions.

Don Davies gave notice of the following motion:

That, pursuant to standing order 108(2), this Committee meet for an additional two days for the purpose of the consideration of Bill C-45, An Act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts; and that the Chair be empowered to coordinate the witnesses, to a minimum of 32 witnesses (eight per stakeholder group), the resources, and scheduling necessary to complete this task in accordance with the following guidelines:

1. Witnesses are to represent the following stakeholder groups in four two-hour panel blocks per day:

i. Existing Canadian licenced producers and dispensaries
ii. Producers of edible cannabis products and other non-smokable forms of cannabis
iii. Ordinary Canadians who made a written submission to this Committee regarding C-45
iv. Young Canadians (15-24 years)

2. That witnesses for each panel block be allotted as follows: two Liberals, one Conservative, one NDP.

3. That witnesses be directed to prepare oral remarks for ten minutes in length, and that the witnesses be invited to submit written statements prior to appearing.

4. That the meetings be held prior to Saturday, September 30, 2017.

At 10:35 a.m., the sitting was suspended.

At 10:54 a.m., the sitting resumed.

Brenda Baxter, Norm Keith and Trina Fraser made statements and answered questions.

The Committee observed a moment of silence in memory of the late Mr. Arnold Chan.

At 12:40 p.m., the sitting was suspended.

At 1:53 p.m., the sitting resumed.

Clara Morin Dal Col and Isadore Day made statements and, with Wenda Watteyne, answered questions.

At 3:29 p.m., the sitting was suspended.

At 3:59 p.m., the sitting resumed.

David Hammond, by videoconference from Waterloo, Ontario, Mike Hammoud and Melodie Tilson made statements and, with Pippa Beck, answered questions.

At 5:31 p.m., the sitting was suspended.

At 6:03 p.m., the sitting resumed.

Beau Kilmer, by videoconference from Gramado, Brazil, Kirk Tousaw, by videoconference from Abbotsford, British Columbia, Stephen Rolles, by videoconference from London, United Kingdom and Steven Hoffman made statements and answered questions.

At 7:56 p.m., the Committee adjourned to the call of the Chair.



David Gagnon
Clerk of the Committee